The Immune Response to Viral Infections

G. Torrigiani

ISBN 10: 1468457144 / ISBN 13: 9781468457148

Published by Humana, 2012

About this Item

nach der Bestellung gedruckt Neuware - Printed after ordering - Virus diseases continue to represent serious health problems in most parts of the world. In spite of the fact that diseases such as polio myelitis and measles have been controlled in the industrialized countries by vaccination, vaccines now in use in tropical countries have proved not to be optimal. Further research is needed to develop new vaccines that will be effective in all countries. To do so we need to understand better the immune response to different viruses so that we may be able to maxi mize the protective response of new vaccines and minimize their potential immunopathologic effect. An exciting new discovery which is now being further developed is the possibility of being able to use some viruses (e.g. vaccinia, adenoviruses, etc.), as carriers for other antigens. This may open up the way for the production of vaccines that will be inexpensive and that will confer long lasting immunity after only one injection. This meeting has also served to review our present knowledge of virus diseases which are still of great importance such as hepatitis, dengue and influenza.

Seller Inventory # 9781468457148

Bibliographic Details

• Title: The Immune Response to Viral Infections
• Publisher: Humana
• Publication Date: 2012
• Language: English
• ISBN 10: 1468457144
• ISBN 13: 9781468457148
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 254W x 178H x 18D millimeters 254 millimeters width by 178 millimeters height by 18 millimeters depth
• Weight: 605 grams

About this title

Synopsis

Virus diseases continue to represent serious health problems in most parts of the world. In spite of the fact that diseases such as polio­ myelitis and measles have been controlled in the industrialized countries by vaccination, vaccines now in use in tropical countries have proved not to be optimal. Further research is needed to develop new vaccines that will be effective in all countries. To do so we need to understand better the immune response to different viruses so that we may be able to maxi­ mize the protective response of new vaccines and minimize their potential immunopathologic effect. An exciting new discovery which is now being further developed is the possibility of being able to use some viruses (e.g. vaccinia, adenoviruses, etc.), as carriers for other antigens. This may open up the way for the production of vaccines that will be inexpensive and that will confer long­ lasting immunity after only one injection. This meeting has also served to review our present knowledge of virus diseases which are still of great importance such as hepatitis, dengue and influenza.